Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Arias

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
Shock (Augusta, Ga.)|February 23, 2023
COMPARISON OF THE PREDICTIVE PERFORMANCE OF CARDIOGENIC SHOCK SCORES IN A REAL-WORLD LATIN AMERICA COUNTRYJorge Ortega-Hernández, Héctor González-Pacheco, Rodrigo Gopar Nieto, et al.
Frontiers in Cardiovascular Medicine|August 8, 2024
Adherence to optimal medical therapy and control of cardiovascular risk factors in patients after ST elevation myocardial infarction in MexicoMontserrat Villalobos-Pedroza, Sarai Hernandez-Pastrana, Alexandra Arias-Mendoza, et al.
Oncotarget|May 15, 2018
Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastasesLeticia De Mattos-Arruda, Charlotte K Y Ng, Salvatore Piscuoglio, et al.
Biomedicines|September 28, 2023
Diagnostic Performance of Serum MicroRNAs for ST-Segment Elevation Myocardial Infarction in the Emergency DepartmentBrianda Amezcua-Guerra, Luis M Amezcua-Castillo, Jazmín A Guerra-López, et al.
Cancer Research|May 18, 2022
Activity and Resistance of a Brain-Permeable Paradox Breaker BRAF Inhibitor in Melanoma Brain MetastasisEster Bonfill-Teixidor, Raffaella Iurlaro, Cornelia Handl, et al.
The American Journal of Cardiology|February 25, 2024
Long-Term Outcomes of Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction: A Study from Mexico CityAlexandra Arias-Mendoza, Rodrigo Gopar-Nieto, Jessica Juarez-Tolen, et al.
Frontiers in Cardiovascular Medicine|November 6, 2023
Analysis of immortal-time effect in post-infarction ventricular septal defectHéctor González-Pacheco, Jorge Arturo Ortega-Hernandez, Jesús Ángel Meza-López, et al.
Global Heart|December 13, 2021
Cardiogenic Shock Among Patients with and without Acute Myocardial Infarction in a Latin American Country: A Single-Institution StudyHéctor González-Pacheco, Daniel Manzur-Sandoval, Rodrigo Gopar-Nieto, et al.
Circulation. Heart Failure|April 24, 2026
Circulatory Support Escalation in Cardiogenic Shock Outcomes and Predictors of Successful Escalation from an International, Multi-Center Cardiac Intensive Care RegistryLuca Baldetti, Guglielmo Gallone, Jorge A Ortega-Hernandez, et al.
European Journal of Heart Failure|January 4, 2023
Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: insights from the GALACTIC-HF trialKieran F Docherty, John J V McMurray, Brian L Claggett, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Shock (Augusta, Ga.)|February 23, 2023
COMPARISON OF THE PREDICTIVE PERFORMANCE OF CARDIOGENIC SHOCK SCORES IN A REAL-WORLD LATIN AMERICA COUNTRYJorge Ortega-Hernández, Héctor González-Pacheco, Rodrigo Gopar Nieto, et al.
Frontiers in Cardiovascular Medicine|August 8, 2024
Adherence to optimal medical therapy and control of cardiovascular risk factors in patients after ST elevation myocardial infarction in MexicoMontserrat Villalobos-Pedroza, Sarai Hernandez-Pastrana, Alexandra Arias-Mendoza, et al.
Oncotarget|May 15, 2018
Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastasesLeticia De Mattos-Arruda, Charlotte K Y Ng, Salvatore Piscuoglio, et al.
Biomedicines|September 28, 2023
Diagnostic Performance of Serum MicroRNAs for ST-Segment Elevation Myocardial Infarction in the Emergency DepartmentBrianda Amezcua-Guerra, Luis M Amezcua-Castillo, Jazmín A Guerra-López, et al.
Cancer Research|May 18, 2022
Activity and Resistance of a Brain-Permeable Paradox Breaker BRAF Inhibitor in Melanoma Brain MetastasisEster Bonfill-Teixidor, Raffaella Iurlaro, Cornelia Handl, et al.
The American Journal of Cardiology|February 25, 2024
Long-Term Outcomes of Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction: A Study from Mexico CityAlexandra Arias-Mendoza, Rodrigo Gopar-Nieto, Jessica Juarez-Tolen, et al.
Frontiers in Cardiovascular Medicine|November 6, 2023
Analysis of immortal-time effect in post-infarction ventricular septal defectHéctor González-Pacheco, Jorge Arturo Ortega-Hernandez, Jesús Ángel Meza-López, et al.
Global Heart|December 13, 2021
Cardiogenic Shock Among Patients with and without Acute Myocardial Infarction in a Latin American Country: A Single-Institution StudyHéctor González-Pacheco, Daniel Manzur-Sandoval, Rodrigo Gopar-Nieto, et al.
Circulation. Heart Failure|April 24, 2026
Circulatory Support Escalation in Cardiogenic Shock Outcomes and Predictors of Successful Escalation from an International, Multi-Center Cardiac Intensive Care RegistryLuca Baldetti, Guglielmo Gallone, Jorge A Ortega-Hernandez, et al.
European Journal of Heart Failure|January 4, 2023
Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: insights from the GALACTIC-HF trialKieran F Docherty, John J V McMurray, Brian L Claggett, et al.
Pageof 13